The leading Turkish pharmaceutical company Abdi Ibrahim purchased 28.5 per cent of the shares of the Swiss biotech company OM…
The leading Turkish pharmaceutical company Abdi Ibrahim purchased 28.5 per cent of the shares of the Swiss biotech company OM…